These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37378874)

  • 1. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
    Bağlan E; Kızıldağ Z; Çağlayan Ş; Çakmak F; Yener GO; Özdel S; Öztürk K; Makay B; Çakan M; Ayaz NA; Sözeri B; Ünsal ŞE; Bülbül M
    Clin Rheumatol; 2023 Oct; 42(10):2855-2860. PubMed ID: 37378874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
    Martini G; Saggioro L; Culpo R; Vittadello F; Meneghel A; Zulian F
    Rheumatology (Oxford); 2021 Mar; 60(3):1387-1391. PubMed ID: 32978631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory arthritis in pediatric patients with morphea.
    Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
    J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate in Linear Scleroderma: Long-Term Efficacy in Fifty Children From a Single Pediatric Rheumatology Center.
    Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F; Martini G
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1259-1263. PubMed ID: 32433808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
    Arthur M; Fett NM; Latour E; Jacobe H; Kunzler E; Florez-Pollack S; Houser J; Sharma S; Prasad S; Femia A; Stern MJ; Pappas-Taffer LK; Gaffney R; Fernandez AP; Knabel D; Cardones AR; Leung N; Laumann A; Yu JM; Zhao J; Vleugels RA; Tkachenko E; Lo K
    JAMA Dermatol; 2020 May; 156(5):521-528. PubMed ID: 32236497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.
    Mansour M; Liy Wong C; Zulian F; Li S; Morishita K; Yeh EA; Stewart K; Laxer RM; Pope E
    Pediatr Dermatol; 2018 Nov; 35(6):761-768. PubMed ID: 30187959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric morphea (localized scleroderma): review of 136 patients.
    Christen-Zaech S; Hakim MD; Afsar FS; Paller AS
    J Am Acad Dermatol; 2008 Sep; 59(3):385-96. PubMed ID: 18571769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
    Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X
    Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma.
    Hardy J; Boralevi F; Mallet S; Cabrera N; Belot A; Phan A; Barbarot S; Duriez-Lasek A; Chiaverini C; Hubiche T; Mahé E; Bégon E; Bourrat E; Boccara O; Aubert H; Lerosey MG; Droitcourt C; Piram M; Mazereeuw-Hautier J;
    Acta Derm Venereol; 2019 May; 99(6):539-543. PubMed ID: 30810215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience.
    Ozdel S; Sönmez HE; Çağlayan Ş; Akgün Ö; Aydın T; Baba Ö; Bağrul İ; Yener GO; Öztürk K; Demir F; Yıldırım DG; Karadağ ŞG; Bağlan E; Çakan M; Kalyoncu M; Makay BB; Ünsal ŞE; Bakkaloğlu S; Bülbül M; Sözeri B; Ayaz NA
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):72. PubMed ID: 37475055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study on clinical subtypes and management of morphea in 10 Italian Dermatological Units.
    Virdi A; Patrizi A; Cambiaghi S; Diociaiuti A; El Hachem M; Schena D; Bassi A; Bonamonte D; Brazzelli V; Belloni Fortina A; Pepe P; DI Lernia V; Neri I
    Ital J Dermatol Venerol; 2021 Aug; 156(4):446-454. PubMed ID: 33070566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study: Impact of consensus treatment plans on systemic therapy of pediatric morphea.
    Do N; Ringold S; Sullivan E; Brandling-Bennett H
    Pediatr Dermatol; 2020 Mar; 37(2):278-283. PubMed ID: 31967352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients.
    Koch SB; Cerci FB; Jorizzo JL; Krowchuk DP
    J Dermatolog Treat; 2013 Dec; 24(6):435-8. PubMed ID: 23758214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localized scleroderma (morphea)].
    Bono W; Dupin N
    Presse Med; 2006 Dec; 35(12 Pt 2):1923-8. PubMed ID: 17159718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
    Li SC; Torok KS; Ishaq SS; Buckley M; Edelheit B; Ede KC; Liu C; Rabinovich CE
    Rheumatology (Oxford); 2021 Aug; 60(8):3817-3825. PubMed ID: 33369667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment in Juvenile Scleroderma.
    Zulian F; Tirelli F
    Curr Rheumatol Rep; 2020 Jun; 22(8):45. PubMed ID: 32591919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations?
    Valões CCM; Novak GV; Brunelli JB; Kozu KT; Toma RK; Silva CA
    Rev Bras Reumatol Engl Ed; 2017; 57(6):521-525. PubMed ID: 29173689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution.
    Melani L; Cardinali C; Giomi B; Schincaglia E; Caproni M; Fabbri P
    Skinmed; 2005; 4(3):188-90. PubMed ID: 15891259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Bullous Morphea Resistant to Methotrexate and Phototherapy Successfully Treated With Mycophenolate Mofetil.
    Cuellar-Barboza A; Alberto Cardenas-De La Garza J; Daniel Villarreal-Villarreal C; Ocampo-Candiani J; Gomez-Flores M; Welsh O; Herz-Ruelas ME
    J Drugs Dermatol; 2018 Oct; 17(10):1123-1125. PubMed ID: 30365594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.